ProfileGDS4718 / 222357_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 66% 65% 61% 68% 62% 59% 61% 72% 60% 59% 70% 46% 54% 62% 63% 64% 58% 69% 84% 56% 64% 63% 64% 60% 60% 69% 79% 75% 66% 63% 72% 68% 61% 75% 58% 54% 65% 64% 58% 66% 71% 75% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.385464
GSM549102patient 115, normal, homogenized [OPG study]6.5357366
GSM549104patient 119, normal, homogenized [OPG study]6.5379665
GSM549108patient 138, normal, homogenized [OPG study]6.2306161
GSM549119patient 077, normal, homogenized [OPG study]6.6730868
GSM549133patient 032, cancer, homogenized [OPG study]6.2317162
GSM549139patient 042, cancer, homogenized [OPG study]6.038359
GSM549099patient 107, normal, homogenized [OPG study]6.1799361
GSM549109patient 139, normal, homogenized [OPG study]7.0284372
GSM549110patient 046, normal, homogenized [OPG study]6.1389460
GSM549114patient 063, normal, homogenized [OPG study]5.9908659
GSM549122patient 082, normal, homogenized [OPG study]6.9003270
GSM549134patient 033, cancer, homogenized [OPG study]5.2684946
GSM549136patient 036, cancer, homogenized [OPG study]5.7052754
GSM549140patient 044, cancer, homogenized [OPG study]6.2768862
GSM549111patient 047, normal, homogenized [OPG study]6.3767563
GSM549113patient 057, normal, homogenized [OPG study]6.4203564
GSM549132patient 031, cancer, homogenized [OPG study]5.9663458
GSM549137patient 038, cancer, homogenized [OPG study]6.8063669
GSM549142patient 047, cancer, homogenized [OPG study]7.9667184
GSM549100patient 110, normal, homogenized [OPG study]5.8799956
GSM549107patient 135, normal, homogenized [OPG study]6.3588464
GSM549115patient 068, normal, homogenized [OPG study]6.349863
GSM549116patient 072, normal, homogenized [OPG study]6.3784464
GSM549120patient 078, normal, homogenized [OPG study]6.1290960
GSM549131patient 030, cancer, homogenized [OPG study]6.1033460
GSM549118patient 074, normal, homogenized [OPG study]6.7863769
GSM549129patient 027, cancer, homogenized [OPG study]7.788179
GSM549123patient 088, normal, homogenized [OPG study]7.3644775
GSM549124patient 006, cancer, homogenized [OPG study]6.5536566
GSM549126patient 015, cancer, homogenized [OPG study]6.3004463
GSM549128patient 025, cancer, homogenized [OPG study]7.1275772
GSM549103patient 117, normal, homogenized [OPG study]6.6742468
GSM549117patient 073, normal, homogenized [OPG study]6.14561
GSM549138patient 041, cancer, homogenized [OPG study]7.366775
GSM549141patient 045, cancer, homogenized [OPG study]5.9872858
GSM549130patient 028, cancer, homogenized [OPG study]5.7259854
GSM549101patient 111, normal, homogenized [OPG study]6.5230965
GSM549105patient 128, normal, homogenized [OPG study]6.4001564
GSM549106patient 134, normal, homogenized [OPG study]6.0015558
GSM549112patient 048, normal, homogenized [OPG study]6.5220566
GSM549125patient 011, cancer, homogenized [OPG study]6.9138871
GSM549127patient 024, cancer, homogenized [OPG study]7.3973575
GSM549135patient 035, cancer, homogenized [OPG study]6.3347463